MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-32-0000899
Oricare Pharma Private Limited
Oricare Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹67.23 Lakh
▼ 0.29% YoY
Net loss · FY 2023
₹1.23 Lakh
Net margin -1.8%
EBITDA · FY 2023
₹2.6 Lakh
EBITDA margin 3.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹51.96 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Oricare Pharma Private Limited
Data last updated:
Oricare Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC101803. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sumitra Devi and Pankaj Misra.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H.No. 24 Sagar Co Op H So Po – Naroda Vill: Nava Naroda Tal: Ahmadabad C, Ahmedabad, Gujarat, India – 382330.
As per the financials filed for FY 2023, the company reported a revenue of ₹67.23 Lakh. For the same year it recorded a net loss of ₹1.23 Lakh (net margin -1.8%) and EBITDA of ₹2.6 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
As per MCA filings, the company has open charges of ₹51.96 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Oricare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0000899).
Company details
CIN U74999GJ2018PTC101803
Registration Number 101803
Incorporation Date 13 April 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-UP-32-0000899
Key People
Sumitra Devi Director Pankaj Misra Director Recognitions & Rankings of Oricare Pharma
Contact details
Oricare Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 24 Sagar Co Op H So Po – Naroda Vill: Nava Naroda Tal: Ahmadabad C, Ahmedabad, Gujarat, India – 382330
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oricare Pharma Private Limited, buy the company report.
Comprehensive company report
Oricare Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oricare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oricare Pharma Private Limited, buy the company report.
Financials of Oricare Pharma Private Limited
FY 2023 filings availableOricare Pharma Private Limited reported revenue of ₹67.23 Lakh for FY 2023.
Revenue · FY 2023
₹67.23 Lakh
Net loss · FY 2023
₹1.23 Lakh margin -1.8%
EBITDA · FY 2023
₹2.6 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹67.23 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | -1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oricare Pharma Private Limited, buy the company report.
Board of directors of Oricare Pharma Private Limited
Oricare Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumitra Devi | Director | 13 Apr 2018 | 8 Years 6 Months | Current |
| Pankaj Misra | Director | 13 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Oricare Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medox Remedies Private Limited | ₹67.35 Lakh (FY 2022) | 30.0% | New Delhi, Delhi, India | |||
| Oricare Pharma Private Limitedthis company | ₹67.23 Lakh (FY 2023) | -₹1.23 Lakh | -1.8% | Ahmedabad, Gujarat, India | ||
| Well Rise Pharma Private Limited | ₹67.15 Lakh (FY 2024) | 55.0% | Delhi, India | |||
| Sriramchem Laboratories Private Limited | ₹67.12 Lakh (FY 2024) | 16.0% | Mysore, Karnataka, India | |||
| Astronix Healthcare Private Limited | ₹67.07 Lakh (FY 2019) | Kolkata, West Bengal, India |
To see the full peer comparison of Oricare Pharma Private Limited, buy the company report.
Auditor
Oricare Pharma Private Limited is audited by Vikram Choudhary & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vikram Choudhary & CO. | FY 2023 | 030965C |
Shareholding
The shareholding of Oricare Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oricare Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹51.96 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jun 2020 | 100353507 | Others | ₹7.96 Lakh | Open | |
| 27 Apr 2020 | 100336117 | Others | ₹4 Lakh | Open | |
| 08 Aug 2019 | 100281310 | Others | ₹40 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Oricare Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Cheque dishonour complaint | Filed against the company by M/S Aashi Pharmaceuticals | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary cases) | Filed against the company by an individual | Pending |
To see the full case history of Oricare Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oricare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oricare Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Oricare Pharma Private Limited, buy the company report.
Recent activity
Oricare Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pankaj Misra was appointed as Director on 13 Apr 2018.
AGM
Oricare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Oricare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 7.96 Lakh with Charge ID 100353507 was registered on 02 Jun 2020.
Charges
A charge with Others amounted to Rs. 4.00 Lakh with Charge ID 100336117 was registered on 27 Apr 2020.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100281310 was registered on 08 Aug 2019.
Appointed
Pankaj Misra was appointed as Director.
Appointed
Sumitra Devi was appointed as Director.
Incorporation
13 Apr 2018
Oricare Pharma Private Limited was registered on 13 Apr 2018 with Roc Ahmedabad & aged 8 years 6 months as per MCA records.
Frequently asked questions
Oricare Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 April 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC101803.
Oricare Pharma has 2 current directors:
- Sumitra Devi - Director
- Pankaj Misra - Director
The latest financial statements of Oricare Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
No. Oricare Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Oricare Pharma is U74999GJ2018PTC101803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oricare Pharma has 2 court cases on record: 2 filed against it. 2 are pending.
Oricare Pharma was incorporated on 13 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Oricare Pharma by revenue are Medox Remedies Private Limited, Well Rise Pharma Private Limited, Sriramchem Laboratories Private Limited, Astronix Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pankaj Misra was appointed as Director on 13 Apr 2018. Sumitra Devi was appointed as Director on 13 Apr 2018.
Yes, Oricare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0000899).
The registered office of Oricare Pharma is at H.No. 24 Sagar Co Op H So Po – Naroda Vill: Nava Naroda Tal: Ahmadabad C, Ahmedabad, Gujarat, India – 382330.